CISH and neoplasm: Zhu et al. have recently developed human CISH-knockout NK cells using an iPSC-NK cell platform, which demonstrated increased IL-15-mediated JAK–STAT signaling activity, improved expansion and increased cytotoxic activity against multiple tumor cell lines when maintained at low cytokine concentrations [146].